Nuo Therapeutics, Inc. (AURX) › Shareholders' EquityNuo Therapeutics, Inc. (AURX) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2009: $976.1K2010: -$79.3K2011: $3.28M2012: $38.00M2013: $26.31M2014: $15.47M2015: -$36.56M2016: $12.49M2017: $482.9K2018: -$82.0K2019: -$1.21M2020: -$503.5K2021: $792.8K2022: $2.19M2023: $1.04M2024: $513.7K2025: -$956.6K-$956.6K2009Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025-$956.6K-286.2%2024$513.7K-50.6%2023$1.04M-52.6%2022$2.19M+176.4%2021$792.8K+257.5%2020-$503.5K+58.4%2019-$1.21M-1374.8%2018-$82.0K-117.0%2017$482.9K-96.1%2016$12.49M+134.2%2015-$36.56M-336.4%2014$15.47M-41.2%2013$26.31M-30.8%2012$38.00M+1058.1%2011$3.28M+4240.7%2010-$79.3K-108.1%2009$976.1K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share